Literature DB >> 22842598

A phage display vector optimized for the generation of human antibody combinatorial libraries and the molecular cloning of monoclonal antibody fragments.

Laura Solforosi1, Nicasio Mancini, Filippo Canducci, Nicola Clementi, Giuseppe Andrea Sautto, Roberta Antonia Diotti, Massimo Clementi, Roberto Burioni.   

Abstract

A novel phagemid vector, named pCM, was optimized for the cloning and display of antibody fragment (Fab) libraries on the surface of filamentous phage. This vector contains two long DNA "stuffer" fragments for easier differentiation of the correctly cut forms of the vector. Moreover, in pCM the fragment at the heavy-chain cloning site contains an acid phosphatase-encoding gene allowing an easy distinction of the Escherichia coli cells containing the unmodified form of the phagemid versus the heavy-chain fragment coding cDNA. In pCM transcription of heavy-chain Fd/gene III and light chain is driven by a single lacZ promoter. The light chain is directed to the periplasm by the ompA signal peptide, whereas the heavy-chain Fd/coat protein III is trafficked by the pelB signal peptide. The phagemid pCM was used to generate a human combinatorial phage display antibody library that allowed the selection of a monoclonal Fab fragment antibody directed against the nucleoprotein (NP) of Influenza A virus.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22842598

Source DB:  PubMed          Journal:  New Microbiol        ISSN: 1121-7138            Impact factor:   2.479


  12 in total

Review 1.  Possible future monoclonal antibody (mAb)-based therapy against arbovirus infections.

Authors:  Giuseppe Sautto; Nicasio Mancini; Giacomo Gorini; Massimo Clementi; Roberto Burioni
Journal:  Biomed Res Int       Date:  2013-08-22       Impact factor: 3.411

2.  Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein.

Authors:  Giuseppe A Sautto; Karin Wisskirchen; Nicola Clementi; Matteo Castelli; Roberta A Diotti; Julia Graf; Massimo Clementi; Roberto Burioni; Ulrike Protzer; Nicasio Mancini
Journal:  Gut       Date:  2015-02-06       Impact factor: 23.059

Review 3.  Multiantibody strategies for HIV.

Authors:  Andrew Hiatt; Larry Zeitlin; Kevin J Whaley
Journal:  Clin Dev Immunol       Date:  2013-06-06

Review 4.  Molecular signatures of hepatitis C virus (HCV)-induced type II mixed cryoglobulinemia (MCII).

Authors:  Giuseppe Sautto; Nicasio Mancini; Massimo Clementi; Roberto Burioni
Journal:  Viruses       Date:  2012-11-08       Impact factor: 5.048

Review 5.  Influenza B-cells protective epitope characterization: a passkey for the rational design of new broad-range anti-influenza vaccines.

Authors:  Nicola Clementi; Elena Criscuolo; Matteo Castelli; Nicasio Mancini; Massimo Clementi; Roberto Burioni
Journal:  Viruses       Date:  2012-11-14       Impact factor: 5.048

Review 6.  Neutralization interfering antibodies: a "novel" example of humoral immune dysfunction facilitating viral escape?

Authors:  Mancini Nicasio; Giuseppe Sautto; Nicola Clementi; Roberta A Diotti; Elena Criscuolo; Matteo Castelli; Laura Solforosi; Massimo Clementi; Roberto Burioni
Journal:  Viruses       Date:  2012-09-24       Impact factor: 5.048

Review 7.  JC polyomavirus (JCV) and monoclonal antibodies: friends or potential foes?

Authors:  Roberta Antonia Diotti; Akira Nakanishi; Nicola Clementi; Nicasio Mancini; Elena Criscuolo; Laura Solforosi; Massimo Clementi
Journal:  Clin Dev Immunol       Date:  2013-06-25

Review 8.  Human monoclonal antibody-based therapy in the treatment of invasive candidiasis.

Authors:  Francesca Bugli; Margherita Cacaci; Cecilia Martini; Riccardo Torelli; Brunella Posteraro; Maurizio Sanguinetti; Francesco Paroni Sterbini
Journal:  Clin Dev Immunol       Date:  2013-06-26

Review 9.  Structural and antigenic definition of hepatitis C virus E2 glycoprotein epitopes targeted by monoclonal antibodies.

Authors:  Giuseppe Sautto; Alexander W Tarr; Nicasio Mancini; Massimo Clementi
Journal:  Clin Dev Immunol       Date:  2013-07-09

Review 10.  Towards a universal influenza vaccine: different approaches for one goal.

Authors:  Giuseppe A Sautto; Greg A Kirchenbaum; Ted M Ross
Journal:  Virol J       Date:  2018-01-19       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.